TCR V beta 8.1/8.2, FITC, clone: KJ16-133 (KJ-16, KJI6, KJ-I6), eBioscience™
Rat Monoclonal Antibody
Brand: Affymetrix eBioscience 11-5813-81
Additional Details : Weight : 0.25000kg
DescriptionThe ability of T cell receptors (TCR) to discriminate foreign from self-peptides presented by major histocompatibility complex (MHC) class II molecules is essential for an effective adaptive immune response. TCR recognition of self-peptides has been linked to autoimmune disease. Mutant self-peptides have been associated with tumors. Engagement of TCRs by a family of bacterial toxins know as superantigens has been responsible for toxic shock syndrome. Autoantibodies to V beta segments of T cell receptors have been isolated from patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The autoantibodies block TH1-mediated inflammatory autodestructive reactions and are believed to be a method by which the immune system compensates for disease. Most human T cells express the TCR alpha-beta and either CD4 or CD8 molecule (single positive, SP). A small number of T cells lack both CD4 and CD8 (double negative, DN). Increased percentages of alpha-beta DN T cells have been identified in some autoimmune and immunodeficiency disorders. Gamma-delta T cells are primarily found within the epithelium. They show less TCR diversity and recognize antigens differently than alpha-beta T cells. Subsets of gamma-delta T cells have shown antitumor and immunoregulatory activity.
|TCR V beta 8.1/8.2|
|PBS with 0.1% gelatin and 0.09% sodium azide; pH 7.2|
|TCRV beta 8.1; TCRV beta8.1; TCR V beta8.1; TCR V beta8.2; Vb8.1; Vbeta8.1; Vb8.2; Vbeta8.2|
|4° C, store in dark, DO NOT FREEZE!|
|KJ16-133 (KJ-16, KJI6, KJ-I6)|
For Research Use Only.